Chronic obstructive uropathy (including BPH-related)
chronic obstruction · Renal / Electrolyte
Physician-written · Verified by three sets of doctors · Reviewed November 2026
Bedside summary
Progressive renal impairment from longstanding urinary tract obstruction (commonly bladder outlet obstruction from BPH, but also strictures, stones, pelvic malignancy or retroperitoneal fibrosis). Relief of obstruction can recover function but risks post-obstructive diuresis.
Red flags
- Obstruction with fever/sepsis (needs emergency decompression)
- Severe hyperkalaemia or fluid overload
- Anuria (bilateral or solitary-kidney obstruction)
- Marked post-obstructive diuresis with hypovolaemia/electrolyte derangement
- Underlying malignancy causing obstruction
Assessment
Differential diagnosis
- Bladder outlet obstruction (BPH, prostate cancer, stricture)
- Bilateral ureteric obstruction (stones, pelvic malignancy, retroperitoneal fibrosis)
- Neurogenic bladder
- Obstruction of a solitary/functioning kidney
- Papillary necrosis with obstruction
- Ureteric obstruction from external compression
Investigations
- Renal ultrasound (hydronephrosis, bladder residual volume)
- Post-void bladder scan/residual volume
- U&E/creatinine and electrolytes (hyperkalaemia, acidosis)
- Urinalysis and culture
- CT urogram/MRI to define level and cause
- PSA/prostate exam; cross-sectional imaging for malignancy or retroperitoneal fibrosis
Management
- Confirm obstruction with imaging (hydronephrosis and/or raised post-void residual) and identify the level and cause
- Relieve obstruction promptly: urethral/suprapubic catheter for bladder outlet obstruction, nephrostomy/ureteric stent for upper-tract obstruction
- Treat infected obstruction as an emergency with decompression plus antibiotics
- Correct life-threatening complications (hyperkalaemia, acidosis, fluid overload)
- Monitor for post-obstructive diuresis after relief: watch urine output, weight, U&E and replace fluids/electrolytes judiciously
- Avoid over-replacement that perpetuates physiological diuresis; replace a proportion of large urine losses
- Identify and treat the underlying cause (BPH medical/surgical therapy, stone removal, stenting/surgery for malignancy, steroids for retroperitoneal fibrosis)
- Assess recovery of renal function over subsequent days to weeks
- Manage bladder dysfunction and plan trial without catheter or definitive surgery (e.g. TURP) as appropriate
- Address CKD if function does not fully recover
- Prevent recurrence (ongoing BPH therapy, stone prevention, surveillance of malignancy)
- Provide urology and nephrology follow-up
Drugs & doses
Tamsulosin 400 micrograms PO once daily (BPH-related outlet obstruction)
Finasteride 5 mg PO once daily (BPH with enlarged prostate)
Culture-directed antibiotics for infected obstruction (e.g. gentamicin 5-7 mg/kg IV daily + amoxicillin per policy)
IV fluids (balanced crystalloid) titrated to replace a proportion of post-obstructive diuresis losses
Prednisolone (for retroperitoneal fibrosis, specialist-directed)
Disposition
Urology for decompression and definitive treatment; nephrology for AKI/CKD and electrolyte management. Admit for infected obstruction, significant AKI or post-obstructive diuresis monitoring.
Complications & pitfalls
- Post-obstructive diuresis with volume/electrolyte depletion
- Irreversible CKD if obstruction prolonged
- Urosepsis
- Hyperkalaemia and metabolic acidosis
- Recurrent obstruction
Exam pearls
- Relieve obstruction first — function often recovers, especially if duration is short
- Anticipate and monitor post-obstructive diuresis, replacing only a proportion of losses
- Infected obstruction is a surgical emergency needing decompression, not antibiotics alone
- Bilateral or solitary-kidney obstruction is the usual cause of obstructive AKI/CKD
- A palpable bladder and high post-void residual point to outlet obstruction
Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.